Michael Glickman, MD, Acting Director of the Marie-Josée Kravis Center for Cancer Immunobiology
Collaboration is the key to driving new discoveries in the field of immunotherapy.
With that goal, the new Marie-Josée Kravis Center for Cancer Immunobiology (CCI) at Memorial Sloan Kettering Cancer Center (MSK) brings together experts from a variety of disciplines and provides them with the most advanced technology and computational approaches for harnessing patient data and sponsoring discoveries that will lead to clinical trials. Our renowned specialists will bring new treatments directly to patients and help train the next generation of immuno-oncology scientists.
The multidisciplinary teams nurtured by this center will enable MSK researchers and clinicians to identify new therapeutic targets and novel immunotherapy treatments, with an emphasis on developing new cell therapies and tumor vaccines.
Through the CCI, scientists have ready access to the state-of-the-art technology they need, including:
- A biobank of tumor samples, immune cells, and other biologically relevant patient samples that can be accessed by the MSK community for projects furthering knowledge of the immune system.
- Novel immunodiagnostic assays with a focus on immuno-oncology discovery, cell engineering, and cancer vaccines.
- Computational immuno-oncology capabilities.
- Staffing to support these initiatives.
Continuing MSK’s historic leadership in this field, the CCI will help shape a future where immune-based therapies redefine the possibilities of cancer medicine.
Related Programs and Facilities
Human Oncology and Pathogenesis Program
At the forefront of translational research, bridging the gap between the basic science and clinical research worlds.
The Olayan Center for Cancer Vaccines at MSK
Pioneering science and clinical trials to accelerate precision cancer vaccines.
Center for Cell Engineering
A unique physician-scientist partnership among researchers from Memorial Hospital and the Sloan Kettering Institute focused on devising and implementing innovative cell therapies for cancer and other diseases.
Cell Therapy and Cell Engineering Facility Core
Develops, validates, and implements procedures critical to gene-transfer-related clinical research.
The Center for Experimental Immuno-Oncology
Organizes and expands the MSK research community investigating the full spectrum of basic science relevant to the interaction of the immune system with tumors.
EIO Cell Bank
A shared tumor tissue resource, open to all MSK researchers, that helps enable the translation of basic immuno-oncology research to human tumors.
Immunology Program
World leaders in the study of innate and adaptive immunity, investigating how it is regulated and how it interacts with threats to the host. Scientists from the program have helped pioneer the translation of laboratory findings into effective clinical applications.
The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project
Tackles critical research questions at the interface between tumors and their host ecosystems. It funds laboratory research aimed at understanding cancer as a problem of malignant cells empowered or defeated by the ecosystems.
Leadership
Alfred P. Sloan Chair
Executive Committee
Edward P. Evans Endowed Chair for Myelodysplastic Syndromes (MDS) at MSK; Senior Vice President, Memorial Hospital, Translational Research
Chair, Human Oncology & Pathogenesis
Principal Investigator, Associate Member
Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Contact Us
To learn more about the CCI and resources that are available, please contact:
Jessica Gotterer
Director, Research Initiatives, Sloan Kettering Institute
gotterej@mskcc.org
646-888-3702